Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk

International Journal of Cancer

Volumn 107, Issue 4, 2003, Pages 652-657

  Saintot, Monique ^a   Malaveille, Christian ^b   Hautefeuille, Agnès ^b   Gerber, Mariette ^a,c  

^a CENTRE VAL D AURELLE   (France)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

Author keywords

Breast cancer; COMT; CYP1B1; Gene polymorphism; SULT1A1; Tobacco

Indexed keywords

ARYL SULFOTRANSFERASE; CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 1B1; SULFOTRANSFERASE 1A1; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DNA ISOLATION; ENZYME ACTIVITY; ESTROGEN METABOLISM; FEMALE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTOXICITY; GENOTYPE; HETEROZYGOSITY; HETEROZYGOTE; HUMAN; HYDROXYLATION; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SMOKING HABIT; SULFATION AND DESULFURIZATION; TOBACCO;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ARYL HYDROCARBON HYDROXYLASES; ARYLSULFOTRANSFERASE; BREAST NEOPLASMS; CATECHOL O-METHYLTRANSFERASE; DNA, NEOPLASM; DRUG INTERACTIONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING; SULFOTRANSFERASES;

EID: 0142117202     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11432     Document Type: Article

References (51)

1. Kelsey JL, Gammon MD, John EM. Reproductive and hormonal risk factors. Epidemiol Rev 1993;15:36-47.
2. Clavel-Chapelon F, Gerber M. Reproductive factors and breast cancer risk: do they differ according to age at diagnosis. Breast Cancer Res Treat 2002;72:107-15.
3. Kaaks R, Lukanova A. Energy balance and cancer: the role of insulin and insulin-like growth factor-1. Proc Nutrition Soc 2001;60:91-106.
4. Liehr JG. Dual role of oestrogens as hormones and procarcinogens: tumor initiation by metabolic activation of oestrogens. Eur J Cancer Prev 1996;6:3-10.
5. Cavalieri EL, Stack DE, Devanesan PD, Todorovic R, Dwivedy I, Higginbotham S, Johansson SL, Patil KD, Gross ML, Gooden JK, Ramanathan R, Cerny RL, et al. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci 1997;94:10937-42.
6. Zhu BT, Conney AH. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 1998;19:1-27.
7. Hayes CL, Spink DC, Spink BC, Cao JQ, Walker NJ, Sutter TR. 17β-estradiol hydroxylation catalysed by human cytochrome P4501B1. Proc Natl Acad Sci 1996;93:9776-81.
8. Krieger N. Exposure, susceptibility, and breast cancer risk. Breast Cancer Res Treat 1989;13:205-23.
9. IARC. Tobacco smoking. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Lyon, France: IARC, 1986. 38:1-397.
10. Palmer LR, Rosenberg L, Clarke EA, Stolley PD, Warshauer ME, Zauber AG, Shapiro S. Breast cancer and cigarette smoking: a hypothesis. Am J Epidemiol 1991;134:1-13.
11. Williams JA, Phillips DH. Mammary expression of xenobiotic metabolising enzymes and their potential role in breast cancer. Cancer Res 2000;60:4667-77.
12. Hecht SS. Tobacco smoke carcinogens and breast cancer. Environ Mol Mutagen 2002;39:119-26.
13. Terry PD, Rohan TE. Cigarette smoking and the risk of breast cancer in women: a review of the literature. Cancer Epidemiol Biomarkers Prev 2002;11:953-71.
14. Morabia A. Smoking (active and passive) and breast cancer: epidemiologic evidence up to June 2001. Environ Mol Mutagen 2002;39:89-95.
15. Meeks MD, Finch GI. Diluted mainstream cigarette smoke condensates activate estrogen receptor and aryl hydrocarbon receptor-mediated gene transcription. Environ Res 1999;80:9-17.
16. Morabia A, Bernstein M, Ruiz J, Heritier S, Diebold Berger S, Borisch B. Relation of smoking to breast cancer by estrogen receptor status. Int J Cancer 1998;75:339-42.
17. Morabia A, Bernstein M, Heritier S, Khatchatrian N. Relation of breast cancer with passive and active exposure to tobacco smoke. Am J Epidemiol 1996;143:918-28.
18. Johnson KC, Hu J, Mao Y. Passive and active smoking and breast cancer risk in Canada, 1994-97. The Canadian Cancer Registries Epidemiology Research Group. Cancer Causes Control 2000;11:211-21.
19. Lash TL, Aschengrau, A. Active and passive cigarette smoking and the occurrence of breast cancer. Am J Epidemiol 1999;49:5-12.
20. Kropp S Chang-Claude J. Active and passive smoking and risk of breast cancer by age 50 years among German women. Am J Epidemiol 2002;156:616-26.
21. Egan KM, Stampfer MJ, Hunter D, Hankinson S, Rosner BA, Holmes M, Willet WC, Colditz GA. Active and passive smoking in breast cancer: prospective results from the Nurses' health study. Epidemiology 2002;13:138-45.
22. Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS, Guengerich FP. Activation of chemically diverse procarcinogens by human cytochrome P-4501B1. Cancer Res 1996;56:2979-84.
23. Zheng W, Xie DW, Jin F, Cheng JR, Dai Q, Wen WQ, Shu XO, Gao YT. Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2000;9:147-50.
24. Shimada T, Watanabe J, Kawajiri K, Sutter TR, Guengerich FP, Gillam MJ, Inoue K. Catalytic properties of polymorphic human cytochrome P450 1B1 variants. Carcinogenesis 1999;20:1607-13.
25. Bailey LR, Roodi N, Dupont WD, Parl FF. Association of cytochrome 17450 1B1 (CYP1B1): polymorphism with steroid receptor status in breast cancer. Cancer Res 1998;58:5038-41.
26. Hanna IH, Dawling S, Roodi N, Guengerich FP, Parl FF. Cytochrome 17450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res 2000;60:3440-44.
27. Glatt H, Engelke CE, Pabel U, Teubner W, Jones AL, Coughtrie MW, Andrae U, Falany CN, Meinl W. Sulfotransferases: genetics and role in toxicology. Toxicol. Lett 2000;15:341-48.
28. Falany JL, Falany CN. Expression of cytosolic sulfotransferases in normal mammary epithelial cells and breast cancer cell lines. Cancer Res 1996;56:1551-55.
29. Seth P, Lunetta KL, Bell DW, Gray H, Nasser SM, Rhei E, Kaelin CM, Iglehart DJ, Marks JR, Garber JE, Haber DA, Polyak K. Phenol-sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancer. Cancer Res 2000;60:6859-63.
30. Zheng W, Xie D, Cerhan JR, Sellers TA, Wen W, Folsom AR. Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomark Prev 2001;10:89-94.
31. Coughtrie MWH, Gilissen RAH, Shek B, Strange RC, Fryer AA, Jones PW, Bamber DE. Phenol sulphotransferase SULT1A1 polymorphism: molecular diagnosis and allele frequencies in Caucasian and African populations. Biochem J 1999;337:45-9.
32. Nagata K, Yamazoe Y. Pharmacogenetics of sulfotransferase. Annu Rev Pharmacol Toxicol 2000;40:159-76.
33. Raftogianis RB, Wood TC, Otterness DM, Loon JAV, Weinshilboum RM. Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype. Biochem Biophys Res Comm 1997;239:298-304.
34. Nowell SA, Ambrosone CB, Ozawa S, Macleod SL, Mrackova G, Williams S, Plaxco J, Kadlubar FF, Lang NP. Relationship of phenol sulfotransferase activity (SULT1A1) genotype to sulfotransferase activity phenotype in platelet cytosol. Pharmacogenetics 2000;10:789-97.
35. Thompson PA, Shields PG, Freudenheim JL, Stone A, Vena JE, Marshall JR, Graham S, Laughlin R, Nemoto T, Kadlubar FF, Ambrosone CB. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res 1998;58:2107-10.
36. Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S. Polymorphic catechol-O-methyltransferase gene and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2001;10:635-40.
37. Zevin S, Benowitz NL. Drug interactions with tobacco smoking: an update. Clin Pharmacokinet 1999;36:425-38.
38. Begg CB, Zhang ZF. Statistical analysis of molecular epidemiology studies employing case-series. Cancer Epidemiol Biomarkers Prev 1994;3:173-75.
39. Yang Q, Khoury MJ. Evolving methods in genetic epidemiology. III. Gene-environment interaction in epidemiologic research. Epidemiol Rev 1997;19:33-43.
40. Albert PS, Ramasinghe D, Tangrea J, Wacholder S. Limitations of the case-only design for identifying gene-environment interactions. Am J Epidemiol 2001;154:687-93.
41. Goodman MT, Mcduffie K, Kolonel LN, Terada K, Donlon TA, Wilkens LR, Guo C, Le Marchand L. Case-control study of ovarian cancer and polymorphism in genes involved in catechol-estrogen formation and metabolism. Cancer Epidemiol Biomarkers Prev 2001;10:209-16.
42. Wang Y, Spitz MR, Meng-Hsuan Tsou A, Zhang K, Makan N, Wu X. Sulfotransferase (SULT) 1A1 polymorphism as a predisposition factor for lung cancer: a case-control analysis. Lung Cancer 2002;35:137-42.
43. Ambrosone CB, Freudenheim JI, Graham S, Marshall JR, Vena JE, Brasure JR., Michalek AM., Laughlin R, Nemoto T, Gillenwater KA., Harrington AM, Shields PG. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA 1996;276:1494-1501.
44. Spurr NK, Gough AC, Smith CAD, Wolf RC. Genetic analysis of cytochrome P450 system. In: Waterman MR, Johnson ER, eds. Methods in enzymology. New York: Academic Press, 1991 149-66.
45. Ozawa S, Tang YM, Yamazoe Y, Kato R, Lang NP, Kadubar FF. Genetic polymorphism in human liver phenol sulfotransferases involved in the bioactivation of N-hydroxy derivatives of carcinogenic arylamines and heterocyclic amines. Chem Biol Interact 1998;109:237-48.
46. Hoda F, Nicholl D, Bennett P, Arranz M, Aitchinson KJ, Al-Chalabi A. No association between Parkinson' disease and low activity alleles of catechol-O-methyltransferase. Biochem Biophys Res Commun 1996;21:780-4.
47. De Vivo I, Hankinson SE, Li L, Colditz GA, Hunte, DJ. Association of CYP1B1 polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:489-92.
48. Carlini EJ, Raftogianis RB, Wood TC, Jin F, Zheng W, Rebbeck TR. Sulfation pharmacogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjects. Pharmacogenetics 2001;11:57-68.
49. Williams JA. Single nucleotide polymorphisms, metabolic activation and environmental carcinogenesis: why molecular epidemiologists should think about enzyme expression. Carcinogenesis 2001;22:209-14.
50. Adjei AA, Weinshilboum RM. Catecholestrogen sulfation: possible role in carcinogenesis. Biochem Biophys Res Commun 2002;29:402-8.
51. Bamber DE, Fryer AA, Strange RC, Elder JB, Deakin M, Rajagopal R, Fawole A, Gilissen RA, Campbell FC, Coughtrie MW. Phenol sulphotransferase SULT1A1*1 genotype is associated with reduced risk of colorectal cancer. Pharmacogenetics 2001;11:679-85.